

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 7.33599592 |
| 2 | polyketide metabolic process (GO:0030638) | 7.33599592 |
| 3 | doxorubicin metabolic process (GO:0044598) | 7.33599592 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.90456378 |
| 5 | maintenance of protein location in nucleus (GO:0051457) | 5.31236624 |
| 6 | proline transport (GO:0015824) | 5.26986704 |
| 7 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.84159502 |
| 8 | negative regulation of telomerase activity (GO:0051974) | 4.75912340 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.60907265 |
| 10 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.46550192 |
| 11 | regulation of response to osmotic stress (GO:0047484) | 4.43079434 |
| 12 | histone H4-K5 acetylation (GO:0043981) | 4.42273230 |
| 13 | histone H4-K8 acetylation (GO:0043982) | 4.42273230 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.41650744 |
| 15 | negative regulation of cell killing (GO:0031342) | 4.41650744 |
| 16 | negative regulation of phagocytosis (GO:0050765) | 4.33113701 |
| 17 | histone H4-K12 acetylation (GO:0043983) | 4.30400877 |
| 18 | somite rostral/caudal axis specification (GO:0032525) | 4.17798023 |
| 19 | positive regulation of histone deacetylation (GO:0031065) | 4.05076246 |
| 20 | locomotory exploration behavior (GO:0035641) | 3.91572100 |
| 21 | negative regulation of epidermis development (GO:0045683) | 3.86495480 |
| 22 | response to dietary excess (GO:0002021) | 3.85561829 |
| 23 | regulation of mast cell degranulation (GO:0043304) | 3.83083429 |
| 24 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.80011931 |
| 25 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.79745736 |
| 26 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.78564230 |
| 27 | muscle organ morphogenesis (GO:0048644) | 3.73268543 |
| 28 | pre-miRNA processing (GO:0031054) | 3.70008228 |
| 29 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.64772311 |
| 30 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.64621240 |
| 31 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.64621240 |
| 32 | modulation by symbiont of host immune response (GO:0052553) | 3.64621240 |
| 33 | positive regulation by symbiont of host defense response (GO:0052509) | 3.64621240 |
| 34 | modulation by symbiont of host defense response (GO:0052031) | 3.64621240 |
| 35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.64621240 |
| 36 | positive regulation of protein deacetylation (GO:0090312) | 3.64027273 |
| 37 | histone H4-K16 acetylation (GO:0043984) | 3.63978272 |
| 38 | regulation of leukocyte degranulation (GO:0043300) | 3.60931737 |
| 39 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.57976403 |
| 40 | protein localization to kinetochore (GO:0034501) | 3.51391065 |
| 41 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.47173108 |
| 42 | heterochromatin organization (GO:0070828) | 3.45361966 |
| 43 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.41875981 |
| 44 | hormone catabolic process (GO:0042447) | 3.41524048 |
| 45 | mitochondrion distribution (GO:0048311) | 3.37971526 |
| 46 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.37857449 |
| 47 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.34825110 |
| 48 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.34740473 |
| 49 | regulation of ARF protein signal transduction (GO:0032012) | 3.33686346 |
| 50 | detection of temperature stimulus (GO:0016048) | 3.32577616 |
| 51 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.32424128 |
| 52 | positive regulation of macrophage cytokine production (GO:0060907) | 3.31193165 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.29029891 |
| 54 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.27248770 |
| 55 | response to peptidoglycan (GO:0032494) | 3.23973228 |
| 56 | regulation of regulated secretory pathway (GO:1903305) | 3.22212971 |
| 57 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.21818955 |
| 58 | macrophage activation involved in immune response (GO:0002281) | 3.21426003 |
| 59 | retinoic acid receptor signaling pathway (GO:0048384) | 3.20639255 |
| 60 | tachykinin receptor signaling pathway (GO:0007217) | 3.18699732 |
| 61 | positive regulation of Rap GTPase activity (GO:0032854) | 3.18646563 |
| 62 | regulation of early endosome to late endosome transport (GO:2000641) | 3.18250566 |
| 63 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.18114865 |
| 64 | negative regulation of cell size (GO:0045792) | 3.14951853 |
| 65 | interferon-gamma production (GO:0032609) | 3.12596580 |
| 66 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.12524162 |
| 67 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.11351105 |
| 68 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.08849727 |
| 69 | cytidine metabolic process (GO:0046087) | 3.07114499 |
| 70 | cytidine catabolic process (GO:0006216) | 3.07114499 |
| 71 | cytidine deamination (GO:0009972) | 3.07114499 |
| 72 | sodium ion export (GO:0071436) | 3.06555743 |
| 73 | rRNA transcription (GO:0009303) | 3.05608198 |
| 74 | glutamate secretion (GO:0014047) | 3.05450763 |
| 75 | primitive streak formation (GO:0090009) | 3.01355369 |
| 76 | maintenance of protein localization in organelle (GO:0072595) | 2.99859912 |
| 77 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.99645846 |
| 78 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.99633333 |
| 79 | maternal placenta development (GO:0001893) | 2.98889353 |
| 80 | leukocyte aggregation (GO:0070486) | 2.98739463 |
| 81 | detection of other organism (GO:0098543) | 2.95958347 |
| 82 | regulation of activation of Janus kinase activity (GO:0010533) | 2.95314815 |
| 83 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.95114471 |
| 84 | layer formation in cerebral cortex (GO:0021819) | 2.94872913 |
| 85 | adaptation of signaling pathway (GO:0023058) | 2.92445621 |
| 86 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.92117722 |
| 87 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.91445851 |
| 88 | mannose metabolic process (GO:0006013) | 2.91096236 |
| 89 | negative regulation of interleukin-12 production (GO:0032695) | 2.90635830 |
| 90 | regulation of Rap GTPase activity (GO:0032317) | 2.90006589 |
| 91 | response to muramyl dipeptide (GO:0032495) | 2.89630373 |
| 92 | detection of bacterium (GO:0016045) | 2.89355546 |
| 93 | hypotonic response (GO:0006971) | 2.89029617 |
| 94 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.88433169 |
| 95 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.84774385 |
| 96 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.82925693 |
| 97 | neutrophil activation involved in immune response (GO:0002283) | 2.81578117 |
| 98 | cell-cell junction maintenance (GO:0045217) | 2.80103858 |
| 99 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.78856262 |
| 100 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.78569606 |
| 101 | mitotic sister chromatid segregation (GO:0000070) | 2.78424422 |
| 102 | cellular modified amino acid catabolic process (GO:0042219) | 2.78413281 |
| 103 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.76921492 |
| 104 | germinal center formation (GO:0002467) | 2.76247128 |
| 105 | signal complex assembly (GO:0007172) | 2.76195724 |
| 106 | positive regulation of synapse maturation (GO:0090129) | 2.75404982 |
| 107 | mRNA stabilization (GO:0048255) | 2.74940933 |
| 108 | RNA stabilization (GO:0043489) | 2.74940933 |
| 109 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.73333394 |
| 110 | positive regulation of muscle cell apoptotic process (GO:0010661) | 2.72937910 |
| 111 | phenol-containing compound catabolic process (GO:0019336) | 2.72731436 |
| 112 | modulation by symbiont of host cellular process (GO:0044068) | 2.70748763 |
| 113 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.69559265 |
| 114 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.69180516 |
| 115 | regulation of synapse structural plasticity (GO:0051823) | 2.68856973 |
| 116 | NLS-bearing protein import into nucleus (GO:0006607) | 2.65846001 |
| 117 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.65539010 |
| 118 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.65020316 |
| 119 | histone H4 deacetylation (GO:0070933) | 2.64799377 |
| 120 | vitamin A metabolic process (GO:0006776) | 2.64477957 |
| 121 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.64476513 |
| 122 | heparin biosynthetic process (GO:0030210) | 2.64073045 |
| 123 | heparin metabolic process (GO:0030202) | 2.64073045 |
| 124 | positive regulation of myotube differentiation (GO:0010831) | 2.63855797 |
| 125 | regulation of macrophage cytokine production (GO:0010935) | 2.62886290 |
| 126 | detection of external biotic stimulus (GO:0098581) | 2.62832941 |
| 127 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.61924674 |
| 128 | vocalization behavior (GO:0071625) | 2.61098230 |
| 129 | regulation of cilium movement (GO:0003352) | 2.61053956 |
| 130 | coenzyme catabolic process (GO:0009109) | 2.60670880 |
| 131 | response to laminar fluid shear stress (GO:0034616) | 2.60014228 |
| 132 | establishment of endothelial barrier (GO:0061028) | 2.59936120 |
| 133 | regulation of ARF GTPase activity (GO:0032312) | 2.59776665 |
| 134 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.59753088 |
| 135 | apoptotic DNA fragmentation (GO:0006309) | 2.59377457 |
| 136 | negative regulation of type 2 immune response (GO:0002829) | 2.57953300 |
| 137 | detection of molecule of bacterial origin (GO:0032490) | 2.57078937 |
| 138 | activation of MAPKKK activity (GO:0000185) | 2.56420784 |
| 139 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.56305314 |
| 140 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.56202286 |
| 141 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.56090755 |
| 142 | notochord development (GO:0030903) | 2.55664496 |
| 143 | positive regulation of protein dephosphorylation (GO:0035307) | 2.55629684 |
| 144 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.55112050 |
| 145 | positive regulation of axon extension (GO:0045773) | 2.54857295 |
| 146 | L-amino acid import (GO:0043092) | 2.54731969 |
| 147 | mitochondrion localization (GO:0051646) | 2.53679353 |
| 148 | synaptic vesicle exocytosis (GO:0016079) | 2.53459103 |
| 149 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.53423196 |
| 150 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.53403726 |
| 151 | chromatin assembly (GO:0031497) | 2.53111268 |
| 152 | neuromuscular process controlling balance (GO:0050885) | 2.52601022 |
| 153 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.51689564 |
| 154 | neurotransmitter secretion (GO:0007269) | 2.51361036 |
| 155 | exploration behavior (GO:0035640) | 2.51020620 |
| 156 | cell migration involved in gastrulation (GO:0042074) | 2.50930618 |
| 157 | cell migration in hindbrain (GO:0021535) | 2.50401229 |
| 158 | protein localization to endosome (GO:0036010) | 2.50375662 |
| 159 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.44730363 |
| 160 | stress fiber assembly (GO:0043149) | 2.44240931 |
| 161 | detection of biotic stimulus (GO:0009595) | 2.41908028 |
| 162 | cellular response to epinephrine stimulus (GO:0071872) | 2.39454025 |
| 163 | granulocyte activation (GO:0036230) | 2.38833893 |
| 164 | regulation of gamma-delta T cell activation (GO:0046643) | 2.38074912 |
| 165 | regulation of mast cell activation (GO:0033003) | 2.37204748 |
| 166 | adenosine receptor signaling pathway (GO:0001973) | 2.35522083 |
| 167 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.35461262 |
| 168 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.34238920 |
| 169 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.33995979 |
| 170 | negative regulation of granulocyte differentiation (GO:0030853) | 2.32130668 |
| 171 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.30910716 |
| 172 | modulation by virus of host process (GO:0019054) | 2.30372924 |
| 173 | apoptotic process involved in morphogenesis (GO:0060561) | 2.29688280 |
| 174 | negative regulation of myotube differentiation (GO:0010832) | 2.29303233 |
| 175 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.28846762 |
| 176 | regulation of type 2 immune response (GO:0002828) | 2.27745903 |
| 177 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.27259279 |
| 178 | creatine metabolic process (GO:0006600) | 2.25920657 |
| 179 | myeloid cell activation involved in immune response (GO:0002275) | 2.25887683 |
| 180 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.25799473 |
| 181 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.25032567 |
| 182 | response to host immune response (GO:0052572) | 2.25032567 |
| 183 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.24656542 |
| 184 | cellular response to catecholamine stimulus (GO:0071870) | 2.23446950 |
| 185 | cellular response to monoamine stimulus (GO:0071868) | 2.23446950 |
| 186 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.22873792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.71019015 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.53517947 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.53517947 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.53517947 |
| 5 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.92032358 |
| 6 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.62762996 |
| 7 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.51604069 |
| 8 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.45505361 |
| 9 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.41142300 |
| 10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.38356271 |
| 11 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 2.21756917 |
| 12 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.20642867 |
| 13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.13027133 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.09092674 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.07764220 |
| 16 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.06607187 |
| 17 | * KDM2B_26808549_Chip-Seq_K562_Human | 2.05034707 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.03030340 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.98944693 |
| 20 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.98629676 |
| 21 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.98206526 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98003777 |
| 23 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.90939092 |
| 24 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.87079907 |
| 25 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.83080008 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77964015 |
| 27 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76776732 |
| 28 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.72918290 |
| 29 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.69751020 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.68324054 |
| 31 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.67660173 |
| 32 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.67370920 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65761839 |
| 34 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.64602270 |
| 35 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.63622291 |
| 36 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.61602409 |
| 37 | * MAF_26560356_Chip-Seq_TH1_Human | 1.58473932 |
| 38 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.56597200 |
| 39 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.54607773 |
| 40 | MAF_26560356_Chip-Seq_TH2_Human | 1.53574161 |
| 41 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.51649196 |
| 42 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.50751171 |
| 43 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.49492500 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47640925 |
| 45 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.46960387 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.46911049 |
| 47 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46207036 |
| 48 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.45701914 |
| 49 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43668127 |
| 50 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.41965307 |
| 51 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41582739 |
| 52 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.41165781 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.41079225 |
| 54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39662850 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39619603 |
| 56 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.39354071 |
| 57 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38857326 |
| 58 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38676233 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37953561 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33766445 |
| 61 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33530430 |
| 62 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33009474 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31785682 |
| 64 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31695341 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31220331 |
| 66 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.31157567 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30923802 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30108931 |
| 69 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.29715971 |
| 70 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28695444 |
| 71 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28186044 |
| 72 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.27802680 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.26979636 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26289291 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25807434 |
| 76 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25020785 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24836719 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24268593 |
| 79 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23918926 |
| 80 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.20839024 |
| 81 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.20180092 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20150211 |
| 83 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19901815 |
| 84 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.19269157 |
| 85 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17952030 |
| 86 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17779216 |
| 87 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.17461309 |
| 88 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15948403 |
| 89 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.15619106 |
| 90 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.15619106 |
| 91 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.15562203 |
| 92 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12985490 |
| 93 | * P68_20966046_ChIP-Seq_HELA_Human | 1.11678650 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11626410 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11586706 |
| 96 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.10872809 |
| 97 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.10827037 |
| 98 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.10659280 |
| 99 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.08509538 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08351638 |
| 101 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.08186081 |
| 102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07998134 |
| 103 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.07892739 |
| 104 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07702787 |
| 105 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07387423 |
| 106 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03906935 |
| 107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03899135 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03199616 |
| 109 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.03189988 |
| 110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02926802 |
| 111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02901462 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02771980 |
| 113 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.01708726 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01500108 |
| 115 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01485101 |
| 116 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.00968889 |
| 117 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.99888174 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99215996 |
| 119 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.98701675 |
| 120 | * SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98658306 |
| 121 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98140796 |
| 122 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.98120900 |
| 123 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97640564 |
| 124 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.97412915 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96968749 |
| 126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96837128 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96795246 |
| 128 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95946623 |
| 129 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95067972 |
| 130 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94411903 |
| 131 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94297673 |
| 132 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94192333 |
| 133 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93002395 |
| 134 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.92701042 |
| 135 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.92483417 |
| 136 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91743831 |
| 137 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.91446486 |
| 138 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.90675205 |
| 139 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.89464090 |
| 140 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.88990066 |
| 141 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.88843778 |
| 142 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85759846 |
| 143 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85705786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004858_abnormal_nervous_system | 4.68935477 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.19379960 |
| 3 | MP0002254_reproductive_system_inflammat | 3.58583430 |
| 4 | MP0003436_decreased_susceptibility_to | 3.32334795 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.27031895 |
| 6 | MP0003122_maternal_imprinting | 3.11975016 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.09920254 |
| 8 | MP0008961_abnormal_basal_metabolism | 3.02244204 |
| 9 | MP0003011_delayed_dark_adaptation | 2.90630246 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.75825700 |
| 11 | MP0002332_abnormal_exercise_endurance | 2.56897392 |
| 12 | MP0006292_abnormal_olfactory_placode | 2.56686879 |
| 13 | MP0005499_abnormal_olfactory_system | 2.47831892 |
| 14 | MP0005394_taste/olfaction_phenotype | 2.47831892 |
| 15 | MP0003724_increased_susceptibility_to | 2.38681129 |
| 16 | MP0005451_abnormal_body_composition | 2.35927255 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.23285841 |
| 18 | MP0005075_abnormal_melanosome_morpholog | 2.21186108 |
| 19 | MP0003890_abnormal_embryonic-extraembry | 2.14987379 |
| 20 | MP0003329_amyloid_beta_deposits | 2.13094500 |
| 21 | MP0005167_abnormal_blood-brain_barrier | 2.06249784 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 2.01512269 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.00305558 |
| 24 | MP0002419_abnormal_innate_immunity | 1.95521134 |
| 25 | MP0002653_abnormal_ependyma_morphology | 1.91629803 |
| 26 | MP0000604_amyloidosis | 1.89139058 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.88918365 |
| 28 | MP0008260_abnormal_autophagy | 1.86263638 |
| 29 | MP0006082_CNS_inflammation | 1.84851274 |
| 30 | MP0009046_muscle_twitch | 1.76970223 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.75342716 |
| 32 | MP0003121_genomic_imprinting | 1.75141039 |
| 33 | MP0005025_abnormal_response_to | 1.71640117 |
| 34 | MP0002249_abnormal_larynx_morphology | 1.71402203 |
| 35 | MP0001849_ear_inflammation | 1.64944621 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.63744776 |
| 37 | MP0004130_abnormal_muscle_cell | 1.61887105 |
| 38 | MP0002063_abnormal_learning/memory/cond | 1.57997608 |
| 39 | MP0002064_seizures | 1.55985714 |
| 40 | MP0003075_altered_response_to | 1.54159215 |
| 41 | MP0000751_myopathy | 1.52604437 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.51967792 |
| 43 | MP0003283_abnormal_digestive_organ | 1.51901539 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.50658438 |
| 45 | MP0003279_aneurysm | 1.49062759 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.48907273 |
| 47 | MP0003787_abnormal_imprinting | 1.46464545 |
| 48 | MP0003303_peritoneal_inflammation | 1.44370771 |
| 49 | MP0003879_abnormal_hair_cell | 1.41433032 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.39155273 |
| 51 | MP0004270_analgesia | 1.39047172 |
| 52 | MP0005409_darkened_coat_color | 1.38843850 |
| 53 | MP0000747_muscle_weakness | 1.36720199 |
| 54 | MP0001835_abnormal_antigen_presentation | 1.35968067 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.34436941 |
| 56 | MP0005257_abnormal_intraocular_pressure | 1.33227166 |
| 57 | MP0009840_abnormal_foam_cell | 1.32998548 |
| 58 | MP0003123_paternal_imprinting | 1.29518494 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.29254804 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.29098852 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.26692056 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.26692056 |
| 63 | MP0000920_abnormal_myelination | 1.26083728 |
| 64 | MP0005387_immune_system_phenotype | 1.25831909 |
| 65 | MP0001790_abnormal_immune_system | 1.25831909 |
| 66 | MP0003646_muscle_fatigue | 1.25828962 |
| 67 | MP0001486_abnormal_startle_reflex | 1.24949333 |
| 68 | MP0000678_abnormal_parathyroid_gland | 1.24409309 |
| 69 | MP0001958_emphysema | 1.23780883 |
| 70 | MP0003137_abnormal_impulse_conducting | 1.22971270 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 1.21318369 |
| 72 | MP0002723_abnormal_immune_serum | 1.20586404 |
| 73 | MP0008770_decreased_survivor_rate | 1.19847673 |
| 74 | MP0002420_abnormal_adaptive_immunity | 1.19390566 |
| 75 | MP0003938_abnormal_ear_development | 1.18609186 |
| 76 | MP0001501_abnormal_sleep_pattern | 1.18330876 |
| 77 | MP0001819_abnormal_immune_cell | 1.17898460 |
| 78 | MP0005623_abnormal_meninges_morphology | 1.17627612 |
| 79 | MP0009745_abnormal_behavioral_response | 1.15837713 |
| 80 | MP0001348_abnormal_lacrimal_gland | 1.14527196 |
| 81 | MP0002127_abnormal_cardiovascular_syste | 1.13800347 |
| 82 | MP0000750_abnormal_muscle_regeneration | 1.12524859 |
| 83 | MP0000955_abnormal_spinal_cord | 1.12053307 |
| 84 | MP0002088_abnormal_embryonic_growth/wei | 1.10856817 |
| 85 | MP0000685_abnormal_immune_system | 1.10843661 |
| 86 | MP0004947_skin_inflammation | 1.10404170 |
| 87 | MP0005380_embryogenesis_phenotype | 1.10186668 |
| 88 | MP0001672_abnormal_embryogenesis/_devel | 1.10186668 |
| 89 | MP0003984_embryonic_growth_retardation | 1.08450320 |
| 90 | MP0009278_abnormal_bone_marrow | 1.07588027 |
| 91 | MP0002733_abnormal_thermal_nociception | 1.07082802 |
| 92 | MP0005464_abnormal_platelet_physiology | 1.06373926 |
| 93 | MP0004510_myositis | 1.04745013 |
| 94 | MP0002452_abnormal_antigen_presenting | 1.04645194 |
| 95 | MP0005375_adipose_tissue_phenotype | 1.04576908 |
| 96 | MP0002396_abnormal_hematopoietic_system | 1.03456894 |
| 97 | MP0001800_abnormal_humoral_immune | 1.03346679 |
| 98 | MP0002148_abnormal_hypersensitivity_rea | 1.03270257 |
| 99 | MP0005166_decreased_susceptibility_to | 1.02069676 |
| 100 | MP0009785_altered_susceptibility_to | 1.01816242 |
| 101 | MP0004811_abnormal_neuron_physiology | 1.01011348 |
| 102 | MP0000858_altered_metastatic_potential | 1.00584486 |
| 103 | MP0004087_abnormal_muscle_fiber | 1.00090818 |
| 104 | MP0002925_abnormal_cardiovascular_devel | 0.99944019 |
| 105 | MP0002970_abnormal_white_adipose | 0.99654749 |
| 106 | MP0000343_altered_response_to | 0.99316843 |
| 107 | MP0003045_fibrosis | 0.98401805 |
| 108 | MP0003828_pulmonary_edema | 0.98003417 |
| 109 | MP0005390_skeleton_phenotype | 0.95553354 |
| 110 | MP0004036_abnormal_muscle_relaxation | 0.95532983 |
| 111 | MP0002086_abnormal_extraembryonic_tissu | 0.95443982 |
| 112 | MP0005423_abnormal_somatic_nervous | 0.94279172 |
| 113 | MP0000733_abnormal_muscle_development | 0.92327548 |
| 114 | MP0008874_decreased_physiological_sensi | 0.91642875 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.91179690 |
| 116 | MP0002405_respiratory_system_inflammati | 0.90756969 |
| 117 | MP0005671_abnormal_response_to | 0.89101215 |
| 118 | MP0003091_abnormal_cell_migration | 0.88427174 |
| 119 | MP0008438_abnormal_cutaneous_collagen | 0.86904169 |
| 120 | MP0004381_abnormal_hair_follicle | 0.86700479 |
| 121 | MP0008569_lethality_at_weaning | 0.85608801 |
| 122 | MP0000716_abnormal_immune_system | 0.85204775 |
| 123 | MP0001970_abnormal_pain_threshold | 0.84477717 |
| 124 | MP0002398_abnormal_bone_marrow | 0.83645642 |
| 125 | MP0004085_abnormal_heartbeat | 0.83223848 |
| 126 | MP0002932_abnormal_joint_morphology | 0.83205683 |
| 127 | MP0004883_abnormal_blood_vessel | 0.82360615 |
| 128 | MP0003119_abnormal_digestive_system | 0.81679259 |
| 129 | MP0003763_abnormal_thymus_physiology | 0.81448613 |
| 130 | MP0003633_abnormal_nervous_system | 0.81396371 |
| 131 | MP0002269_muscular_atrophy | 0.81124947 |
| 132 | MP0003453_abnormal_keratinocyte_physiol | 0.80675036 |
| 133 | MP0004808_abnormal_hematopoietic_stem | 0.80571609 |
| 134 | MP0002184_abnormal_innervation | 0.80079224 |
| 135 | MP0000703_abnormal_thymus_morphology | 0.75054622 |
| 136 | MP0002106_abnormal_muscle_physiology | 0.73459969 |
| 137 | MP0002933_joint_inflammation | 0.73338528 |
| 138 | MP0004233_abnormal_muscle_weight | 0.73329264 |
| 139 | MP0004885_abnormal_endolymph | 0.72338458 |
| 140 | MP0002272_abnormal_nervous_system | 0.72169594 |
| 141 | MP0003448_altered_tumor_morphology | 0.72024848 |
| 142 | MP0005248_abnormal_Harderian_gland | 0.71664204 |
| 143 | MP0002092_abnormal_eye_morphology | 0.71235441 |
| 144 | MP0000428_abnormal_craniofacial_morphol | 0.70721114 |
| 145 | MP0003690_abnormal_glial_cell | 0.70356543 |
| 146 | MP0010630_abnormal_cardiac_muscle | 0.69808562 |
| 147 | MP0003935_abnormal_craniofacial_develop | 0.69547751 |
| 148 | MP0008872_abnormal_physiological_respon | 0.68383648 |
| 149 | MP0005266_abnormal_metabolism | 0.68081682 |
| 150 | MP0002734_abnormal_mechanical_nocicepti | 0.67981756 |
| 151 | MP0001293_anophthalmia | 0.66613122 |
| 152 | MP0002114_abnormal_axial_skeleton | 0.66141640 |
| 153 | MP0005076_abnormal_cell_differentiation | 0.65039763 |
| 154 | MP0002084_abnormal_developmental_patter | 0.62862738 |
| 155 | MP0003566_abnormal_cell_adhesion | 0.62817597 |
| 156 | MP0002277_abnormal_respiratory_mucosa | 0.62430312 |
| 157 | MP0002085_abnormal_embryonic_tissue | 0.61215873 |
| 158 | MP0004142_abnormal_muscle_tone | 0.60864863 |
| 159 | MP0003634_abnormal_glial_cell | 0.59751590 |
| 160 | MP0008057_abnormal_DNA_replication | 0.58882267 |
| 161 | MP0009115_abnormal_fat_cell | 0.58398229 |
| 162 | MP0000759_abnormal_skeletal_muscle | 0.58012780 |
| 163 | MP0003191_abnormal_cellular_cholesterol | 0.57752433 |
| 164 | MP0002882_abnormal_neuron_morphology | 0.57584382 |
| 165 | MP0005023_abnormal_wound_healing | 0.57536357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the lower motor neuron (HP:0002366) | 6.22375163 |
| 2 | Bilateral microphthalmos (HP:0007633) | 5.74302901 |
| 3 | Hepatoblastoma (HP:0002884) | 4.77772801 |
| 4 | Hypochromic microcytic anemia (HP:0004840) | 4.59330412 |
| 5 | Ependymoma (HP:0002888) | 3.60928514 |
| 6 | Obstructive sleep apnea (HP:0002870) | 3.60038128 |
| 7 | Multiple enchondromatosis (HP:0005701) | 3.49504367 |
| 8 | Amyotrophic lateral sclerosis (HP:0007354) | 3.44428091 |
| 9 | Rib fusion (HP:0000902) | 3.38288076 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.36543014 |
| 11 | Astrocytoma (HP:0009592) | 3.10052498 |
| 12 | Abnormality of the astrocytes (HP:0100707) | 3.10052498 |
| 13 | Increased variability in muscle fiber diameter (HP:0003557) | 3.09468681 |
| 14 | Neoplasm of the heart (HP:0100544) | 3.02582049 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 2.96201327 |
| 16 | Horizontal nystagmus (HP:0000666) | 2.94586564 |
| 17 | Neoplasm of striated muscle (HP:0009728) | 2.89878584 |
| 18 | Hand muscle atrophy (HP:0009130) | 2.89673766 |
| 19 | Generalized hypotonia (HP:0001290) | 2.83590528 |
| 20 | Renal duplication (HP:0000075) | 2.82605683 |
| 21 | Annular pancreas (HP:0001734) | 2.82588754 |
| 22 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.80210207 |
| 23 | Abnormality of macrophages (HP:0004311) | 2.73217298 |
| 24 | Tetraplegia (HP:0002445) | 2.72337520 |
| 25 | Neurofibrillary tangles (HP:0002185) | 2.71085641 |
| 26 | Testicular atrophy (HP:0000029) | 2.70932118 |
| 27 | Difficulty running (HP:0009046) | 2.69119557 |
| 28 | Myositis (HP:0100614) | 2.69084296 |
| 29 | Distal upper limb amyotrophy (HP:0007149) | 2.64371698 |
| 30 | Upper limb amyotrophy (HP:0009129) | 2.64371698 |
| 31 | Achilles tendon contracture (HP:0001771) | 2.64096419 |
| 32 | Recurrent abscess formation (HP:0002722) | 2.61673275 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 2.58038082 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.58038082 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.58038082 |
| 36 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.55014582 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.53468903 |
| 38 | Orchitis (HP:0100796) | 2.51514830 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51238958 |
| 40 | Obstructive lung disease (HP:0006536) | 2.51238958 |
| 41 | Amblyopia (HP:0000646) | 2.47574446 |
| 42 | Hemiparesis (HP:0001269) | 2.46719711 |
| 43 | Febrile seizures (HP:0002373) | 2.44397854 |
| 44 | Upper motor neuron abnormality (HP:0002127) | 2.43648674 |
| 45 | Ankle clonus (HP:0011448) | 2.40466830 |
| 46 | Intestinal fistula (HP:0100819) | 2.38597632 |
| 47 | Ragged-red muscle fibers (HP:0003200) | 2.38218965 |
| 48 | Abnormality of the Achilles tendon (HP:0005109) | 2.37154893 |
| 49 | Focal seizures (HP:0007359) | 2.36056841 |
| 50 | Gingivitis (HP:0000230) | 2.35889100 |
| 51 | Insomnia (HP:0100785) | 2.35588595 |
| 52 | Rectal fistula (HP:0100590) | 2.35150285 |
| 53 | Rectovaginal fistula (HP:0000143) | 2.35150285 |
| 54 | Abnormality of the nasal mucosa (HP:0000433) | 2.33624823 |
| 55 | Apathy (HP:0000741) | 2.31913735 |
| 56 | Muscle fiber splitting (HP:0003555) | 2.31291054 |
| 57 | Visual hallucinations (HP:0002367) | 2.30579044 |
| 58 | Myokymia (HP:0002411) | 2.29072587 |
| 59 | Dysostosis multiplex (HP:0000943) | 2.26169064 |
| 60 | Cellulitis (HP:0100658) | 2.23375518 |
| 61 | Asymmetric septal hypertrophy (HP:0001670) | 2.21574963 |
| 62 | Metaphyseal cupping (HP:0003021) | 2.20795748 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.20291298 |
| 64 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.19560980 |
| 65 | Rhabdomyosarcoma (HP:0002859) | 2.19092702 |
| 66 | Axonal loss (HP:0003447) | 2.17869239 |
| 67 | Nasal polyposis (HP:0100582) | 2.17860144 |
| 68 | Resting tremor (HP:0002322) | 2.17337822 |
| 69 | Fused cervical vertebrae (HP:0002949) | 2.17293682 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.16226151 |
| 71 | Optic neuritis (HP:0100653) | 2.16226151 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16013274 |
| 73 | Macroorchidism (HP:0000053) | 2.15959920 |
| 74 | Renovascular hypertension (HP:0100817) | 2.15660625 |
| 75 | Large earlobe (HP:0009748) | 2.15638253 |
| 76 | Abnormality of the salivary glands (HP:0010286) | 2.14319901 |
| 77 | Status epilepticus (HP:0002133) | 2.14309319 |
| 78 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14225596 |
| 79 | Partial duplication of thumb phalanx (HP:0009944) | 2.14108731 |
| 80 | Abnormality of the musculature of the hand (HP:0001421) | 2.13644891 |
| 81 | Vaginal fistula (HP:0004320) | 2.13239870 |
| 82 | Increased IgE level (HP:0003212) | 2.12653852 |
| 83 | Diminished motivation (HP:0000745) | 2.11689431 |
| 84 | Exercise-induced myalgia (HP:0003738) | 2.10645929 |
| 85 | Pseudobulbar signs (HP:0002200) | 2.09465772 |
| 86 | Mediastinal lymphadenopathy (HP:0100721) | 2.09453486 |
| 87 | Glioma (HP:0009733) | 2.08937018 |
| 88 | Mitral regurgitation (HP:0001653) | 2.08617766 |
| 89 | Preauricular skin tag (HP:0000384) | 2.08259767 |
| 90 | Gastrointestinal infarctions (HP:0005244) | 2.07996402 |
| 91 | Cerebral aneurysm (HP:0004944) | 2.07256937 |
| 92 | Myopathic facies (HP:0002058) | 2.05728075 |
| 93 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.05436572 |
| 94 | Lymphangioma (HP:0100764) | 2.05402615 |
| 95 | Diplopia (HP:0000651) | 2.04226308 |
| 96 | Abnormality of binocular vision (HP:0011514) | 2.04226308 |
| 97 | Spastic tetraparesis (HP:0001285) | 2.03239389 |
| 98 | Hyperventilation (HP:0002883) | 2.03084053 |
| 99 | Type 1 muscle fiber predominance (HP:0003803) | 2.02241699 |
| 100 | Epileptic encephalopathy (HP:0200134) | 2.01392039 |
| 101 | Skin tags (HP:0010609) | 2.01178216 |
| 102 | Abnormality of the motor neurons (HP:0002450) | 2.00097081 |
| 103 | Abnormal neuron morphology (HP:0012757) | 2.00097081 |
| 104 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.99956737 |
| 105 | Embryonal renal neoplasm (HP:0011794) | 1.99733075 |
| 106 | EMG: neuropathic changes (HP:0003445) | 1.99358474 |
| 107 | Supernumerary nipples (HP:0002558) | 1.97682286 |
| 108 | Peripheral hypomyelination (HP:0007182) | 1.97185330 |
| 109 | Neuronal loss in central nervous system (HP:0002529) | 1.96721536 |
| 110 | Thin bony cortex (HP:0002753) | 1.96097991 |
| 111 | Supranuclear gaze palsy (HP:0000605) | 1.96037711 |
| 112 | Abnormality of chromosome segregation (HP:0002916) | 1.95723588 |
| 113 | Hypochromic anemia (HP:0001931) | 1.95153588 |
| 114 | Hypopigmentation of the fundus (HP:0007894) | 1.94992565 |
| 115 | Disproportionate tall stature (HP:0001519) | 1.94903140 |
| 116 | Absent frontal sinuses (HP:0002688) | 1.94685773 |
| 117 | Pointed chin (HP:0000307) | 1.94396158 |
| 118 | Hyperacusis (HP:0010780) | 1.94363492 |
| 119 | Bowel incontinence (HP:0002607) | 1.93356450 |
| 120 | Partial duplication of the phalanx of hand (HP:0009999) | 1.92039525 |
| 121 | Hemiplegia (HP:0002301) | 1.90722723 |
| 122 | Polygenic inheritance (HP:0010982) | 1.90634209 |
| 123 | Protrusio acetabuli (HP:0003179) | 1.90325766 |
| 124 | Short humerus (HP:0005792) | 1.89822037 |
| 125 | Shawl scrotum (HP:0000049) | 1.89412814 |
| 126 | Increased cerebral lipofuscin (HP:0011813) | 1.88544111 |
| 127 | Broad face (HP:0000283) | 1.87630366 |
| 128 | Abnormality of the pubic bones (HP:0003172) | 1.87052237 |
| 129 | Rapidly progressive (HP:0003678) | 1.86332454 |
| 130 | Elfin facies (HP:0004428) | 1.86252190 |
| 131 | Multifactorial inheritance (HP:0001426) | 1.86198227 |
| 132 | Loss of speech (HP:0002371) | 1.86030945 |
| 133 | Turricephaly (HP:0000262) | 1.85703044 |
| 134 | Abnormal large intestine physiology (HP:0012700) | 1.82980577 |
| 135 | Nuclear cataract (HP:0100018) | 1.82874835 |
| 136 | Bulbar palsy (HP:0001283) | 1.82621642 |
| 137 | Dialeptic seizures (HP:0011146) | 1.81952994 |
| 138 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81884597 |
| 139 | Shallow orbits (HP:0000586) | 1.81771698 |
| 140 | Difficulty climbing stairs (HP:0003551) | 1.81629434 |
| 141 | Open mouth (HP:0000194) | 1.81103699 |
| 142 | Increased connective tissue (HP:0009025) | 1.80199155 |
| 143 | Overriding aorta (HP:0002623) | 1.79682168 |
| 144 | Lymphedema (HP:0001004) | 1.79515731 |
| 145 | Distal lower limb amyotrophy (HP:0008944) | 1.79418843 |
| 146 | Neuroectodermal neoplasm (HP:0030061) | 1.78544190 |
| 147 | Neuroepithelial neoplasm (HP:0030063) | 1.78544190 |
| 148 | Nervous tissue neoplasm (HP:0030060) | 1.78544190 |
| 149 | Round ear (HP:0100830) | 1.78228136 |
| 150 | Periauricular skin pits (HP:0100277) | 1.76570276 |
| 151 | Preauricular pit (HP:0004467) | 1.76570276 |
| 152 | Bifid tongue (HP:0010297) | 1.76530322 |
| 153 | Action tremor (HP:0002345) | 1.76502828 |
| 154 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.76221104 |
| 155 | Spinal muscular atrophy (HP:0007269) | 1.76067319 |
| 156 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.73908343 |
| 157 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.73660062 |
| 158 | Chest pain (HP:0100749) | 1.73464980 |
| 159 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.73232643 |
| 160 | Truncus arteriosus (HP:0001660) | 1.72340943 |
| 161 | Slow saccadic eye movements (HP:0000514) | 1.72050512 |
| 162 | Abnormality of the endocardium (HP:0004306) | 1.70020748 |
| 163 | Flat cornea (HP:0007720) | 1.68180140 |
| 164 | Mutism (HP:0002300) | 1.67568791 |
| 165 | Stridor (HP:0010307) | 1.67364937 |
| 166 | Hypercortisolism (HP:0001578) | 1.66705586 |
| 167 | Peritonitis (HP:0002586) | 1.66628668 |
| 168 | Lower limb amyotrophy (HP:0007210) | 1.66257252 |
| 169 | Amyloidosis (HP:0011034) | 1.63988208 |
| 170 | Gastrointestinal dysmotility (HP:0002579) | 1.63809709 |
| 171 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.63790667 |
| 172 | Bladder diverticulum (HP:0000015) | 1.63115954 |
| 173 | Hyporeflexia of lower limbs (HP:0002600) | 1.61916598 |
| 174 | Ulnar deviation of the wrist (HP:0003049) | 1.61528636 |
| 175 | Spinal canal stenosis (HP:0003416) | 1.61230015 |
| 176 | Meningitis (HP:0001287) | 1.60392755 |
| 177 | Hypercalcemia (HP:0003072) | 1.60289162 |
| 178 | Genu recurvatum (HP:0002816) | 1.59781498 |
| 179 | Gastrointestinal inflammation (HP:0004386) | 1.59041430 |
| 180 | Hypertriglyceridemia (HP:0002155) | 1.58882417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 5.74017263 |
| 2 | GRK5 | 4.19135863 |
| 3 | ERN1 | 4.05002887 |
| 4 | GRK6 | 3.04906796 |
| 5 | TYRO3 | 2.92211832 |
| 6 | MAP3K9 | 2.89053160 |
| 7 | TGFBR2 | 2.63715482 |
| 8 | MAP2K3 | 2.44919894 |
| 9 | CSF1R | 2.23733959 |
| 10 | MATK | 2.09901821 |
| 11 | TRIB3 | 2.00898756 |
| 12 | RIPK1 | 1.98766009 |
| 13 | CDC42BPA | 1.96032412 |
| 14 | ADRBK2 | 1.92505154 |
| 15 | NTRK1 | 1.90067883 |
| 16 | GRK1 | 1.86523844 |
| 17 | SIK2 | 1.66052747 |
| 18 | GRK7 | 1.63800961 |
| 19 | MAPK7 | 1.63572809 |
| 20 | WNK1 | 1.61185423 |
| 21 | MOS | 1.60216588 |
| 22 | ALK | 1.57242594 |
| 23 | MAP2K4 | 1.57166502 |
| 24 | NTRK3 | 1.55440568 |
| 25 | SMG1 | 1.55013041 |
| 26 | IRAK4 | 1.54040965 |
| 27 | CAMK4 | 1.51817454 |
| 28 | MARK2 | 1.40974333 |
| 29 | TAOK2 | 1.36965776 |
| 30 | ZAP70 | 1.31876073 |
| 31 | PAK6 | 1.31652407 |
| 32 | PRKG2 | 1.30267790 |
| 33 | TTN | 1.29115823 |
| 34 | EPHB1 | 1.28050334 |
| 35 | ICK | 1.26452299 |
| 36 | PRKD3 | 1.24586846 |
| 37 | STK10 | 1.22045548 |
| 38 | LIMK1 | 1.21263303 |
| 39 | IRAK3 | 1.20541253 |
| 40 | MAP3K1 | 1.17684477 |
| 41 | STK38 | 1.14875134 |
| 42 | PAK4 | 1.14775036 |
| 43 | CAMKK1 | 1.14684051 |
| 44 | PKN2 | 1.13831037 |
| 45 | NTRK2 | 1.13280106 |
| 46 | FGFR4 | 1.12315797 |
| 47 | KSR2 | 1.10611643 |
| 48 | PDPK1 | 1.08164260 |
| 49 | TYK2 | 1.07036337 |
| 50 | TAOK1 | 1.05964632 |
| 51 | HIPK2 | 1.04981637 |
| 52 | EPHA4 | 1.03279518 |
| 53 | DAPK2 | 0.99751788 |
| 54 | MAP3K10 | 0.98322858 |
| 55 | MAP3K7 | 0.98321501 |
| 56 | BMX | 0.90894211 |
| 57 | PDGFRA | 0.90119571 |
| 58 | MAP3K3 | 0.89297381 |
| 59 | FGFR3 | 0.89217246 |
| 60 | DYRK1B | 0.88325790 |
| 61 | LATS2 | 0.87388145 |
| 62 | CSK | 0.86565483 |
| 63 | FES | 0.86214652 |
| 64 | PRKCH | 0.86045832 |
| 65 | TTK | 0.84821060 |
| 66 | ARAF | 0.84105939 |
| 67 | MINK1 | 0.79369631 |
| 68 | TBK1 | 0.78355726 |
| 69 | TIE1 | 0.77591810 |
| 70 | MAPK12 | 0.77498405 |
| 71 | RPS6KA2 | 0.76758060 |
| 72 | JAK3 | 0.75155750 |
| 73 | RPS6KC1 | 0.72969569 |
| 74 | RPS6KL1 | 0.72969569 |
| 75 | CAMK1D | 0.70333361 |
| 76 | CAMK1G | 0.69302006 |
| 77 | MAP3K6 | 0.68717390 |
| 78 | MAP2K6 | 0.68434136 |
| 79 | PTK2 | 0.66529476 |
| 80 | STK16 | 0.65827429 |
| 81 | TESK1 | 0.64187898 |
| 82 | MARK1 | 0.64160545 |
| 83 | BTK | 0.62764776 |
| 84 | CAMK1 | 0.60860573 |
| 85 | PDK1 | 0.58741006 |
| 86 | ADRBK1 | 0.56671861 |
| 87 | NME2 | 0.56641741 |
| 88 | DDR2 | 0.56149902 |
| 89 | PRKD2 | 0.55200849 |
| 90 | DAPK1 | 0.54701751 |
| 91 | CDK19 | 0.54213855 |
| 92 | RPS6KA6 | 0.53722433 |
| 93 | HCK | 0.53453681 |
| 94 | MTOR | 0.52611162 |
| 95 | SGK3 | 0.52423839 |
| 96 | CDK5 | 0.52409480 |
| 97 | IRAK2 | 0.51632914 |
| 98 | CLK1 | 0.51224780 |
| 99 | CDK7 | 0.51203825 |
| 100 | TNK2 | 0.50120031 |
| 101 | MAP3K4 | 0.48612633 |
| 102 | AKT2 | 0.47929335 |
| 103 | RIPK4 | 0.47783283 |
| 104 | EEF2K | 0.47429798 |
| 105 | PRPF4B | 0.47226299 |
| 106 | SYK | 0.46610863 |
| 107 | CAMKK2 | 0.46267967 |
| 108 | SIK3 | 0.45603385 |
| 109 | MAPK4 | 0.44068424 |
| 110 | STK11 | 0.43687690 |
| 111 | MAPK10 | 0.43326626 |
| 112 | DMPK | 0.42925433 |
| 113 | UHMK1 | 0.42859818 |
| 114 | CDK15 | 0.41815742 |
| 115 | MAP3K13 | 0.39971206 |
| 116 | SIK1 | 0.38705309 |
| 117 | CDK11A | 0.38093383 |
| 118 | MAP4K1 | 0.36372332 |
| 119 | PRKCG | 0.36129396 |
| 120 | PHKG1 | 0.35978914 |
| 121 | PHKG2 | 0.35978914 |
| 122 | CDK18 | 0.35803367 |
| 123 | RPS6KA3 | 0.32948006 |
| 124 | ERBB2 | 0.32860149 |
| 125 | RET | 0.32088093 |
| 126 | IGF1R | 0.30560131 |
| 127 | LMTK2 | 0.30483112 |
| 128 | PTK6 | 0.29383564 |
| 129 | JAK2 | 0.29154724 |
| 130 | FGR | 0.27894833 |
| 131 | MAP3K11 | 0.27778155 |
| 132 | SRC | 0.27601849 |
| 133 | CDK14 | 0.27476766 |
| 134 | NEK1 | 0.27428206 |
| 135 | CHEK2 | 0.27341448 |
| 136 | ITK | 0.26997407 |
| 137 | BLK | 0.26489622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.51364611 |
| 2 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.27072157 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.21004459 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.16691604 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05484923 |
| 6 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.91517475 |
| 7 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.80575232 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.70657789 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 1.66754888 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61761614 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.58326995 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.53335200 |
| 13 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.52665025 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.50930616 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45239571 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42338877 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42231896 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.38399618 |
| 19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.37097474 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35853702 |
| 21 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35627273 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35259421 |
| 23 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.34402823 |
| 24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.32774817 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.32281229 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31975068 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 1.31725541 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.30985011 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30870476 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.26183200 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.22540383 |
| 32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.21765243 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20992104 |
| 34 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.16843871 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.16741814 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.15090637 |
| 37 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.12736314 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11954110 |
| 39 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.11843577 |
| 40 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.11522007 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 1.06398768 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06011958 |
| 43 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05957489 |
| 44 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.05114861 |
| 45 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.04939166 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.03797076 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.03545732 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.02380751 |
| 49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.01511705 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01253730 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.01242693 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00900975 |
| 53 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.00599271 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 0.99275509 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.98436224 |
| 56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.98309996 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97652621 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.97181555 |
| 59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.96558380 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96522499 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96454789 |
| 62 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.96001402 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.95259747 |
| 64 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.94302135 |
| 65 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.92609441 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90886377 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.90671737 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.90101226 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 0.89477816 |
| 70 | Gap junction_Homo sapiens_hsa04540 | 0.87851046 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86957924 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.86774299 |
| 73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.86387740 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86342966 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85195281 |
| 76 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.85078261 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84208742 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83640066 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.83494650 |
| 80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81248122 |
| 81 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.80378733 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80157345 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.78469397 |
| 84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.78081358 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.77961916 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76434128 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76429130 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76371699 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.76076739 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.75598068 |
| 91 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.75314023 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75045966 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.75003094 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.74857734 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74090471 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73475636 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71845676 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71769650 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.70865059 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.70275773 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69773164 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69546307 |
| 103 | Measles_Homo sapiens_hsa05162 | 0.69293489 |
| 104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68319997 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67947477 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67531972 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66177606 |
| 108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66026316 |
| 109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65778707 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65010791 |
| 111 | Focal adhesion_Homo sapiens_hsa04510 | 0.64432430 |
| 112 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63808472 |
| 113 | Insulin secretion_Homo sapiens_hsa04911 | 0.63382525 |
| 114 | Bile secretion_Homo sapiens_hsa04976 | 0.62969999 |
| 115 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62895902 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62371894 |
| 117 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62261757 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61787982 |
| 119 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.61648292 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61374404 |
| 121 | Shigellosis_Homo sapiens_hsa05131 | 0.61123552 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.60964068 |
| 123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59463309 |
| 124 | Axon guidance_Homo sapiens_hsa04360 | 0.59113297 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58643785 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58552599 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57992333 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.56215466 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55385725 |
| 130 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54468370 |
| 131 | Melanogenesis_Homo sapiens_hsa04916 | 0.54384525 |
| 132 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53402529 |
| 133 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52736891 |
| 134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52447895 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52388487 |
| 136 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51398856 |
| 137 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50919979 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50442686 |

